London, United Kingdom--(Newsfile Corp. - February 25, 2025) - Edison issues report on Accsys Technologies (AIM: AXS). At its investor strategy day, Accsys set financial targets for the coming ...

Morgan Stanley raised the firm’s price target on Axsome Therapeutics (AXSM) to $190 from $125 and keeps an Overweight rating on the shares.

AXIS Capital Holdings Limited, through its subsidiaries, provides various specialty insurance and reinsurance products in Bermuda, the United States, and internationally. It operates through two ...

Axs Adaptive Plus Fund earns a Low Process Pillar rating. The main detractor from the rating is the parent firm's five-year risk-adjusted success ratio of 11%. The measure indicates the percentage ...

But McGlay’s dreams of leading a team of “play-to-earn” cryptocurrency gamers focused on the Axie Infinity game quickly fell apart as crypto prices crashed, leaving the 32-year-old with ...

Shares in Axsome Therapeutics have rocketed on FDA approval of its depression therapy Auvelity (formerly AXS-05) – a year after its approval was held up by the regulator.

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

After hours: February 21 at 5:29:10 PM EST ...

While the UN Global Compact logo is for use by our initiative only, we encourage participants in good standing to use the Endorser "We Support" logo. It can be used, for example, on websites and ...